About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Quant Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesDivi's Laboratories Limited9.88926237341.2410
Domestic EquitiesAster DM Healthcare Limited9.457370516439.4398
Domestic EquitiesRPG Life Sciences Limited7.873215052932.8334
Domestic EquitiesSequent Scientific Limited6.7950147712628.3372
Domestic EquitiesPfizer Ltd6.49204823127.0735
Domestic EquitiesAlivus Life Sciences6.147624629825.6372
Domestic EquitiesZydus Wellness Ltd5.999512834625.0198
Domestic EquitiesAurobindo Pharma Limited5.980821730024.9417
Domestic EquitiesHDFC Life Insurance Co Ltd5.806231168824.2135
Domestic EquitiesSMS Pharmaceuticals Limited5.289483321322.0585
Domestic EquitiesHFCL Limited5.0198239000020.9340
Domestic EquitiesSun Pharmaceutical Industries Limited3.10757724912.9593
Domestic EquitiesLupin Limited2.67475697611.1542
Domestic EquitiesSuraksha Diagnostic Limited2.598033741310.8343
Domestic EquitiesLaxmi Dental Limited0.5008544252.0886
Total 83.6310 348.7660
Cash & Cash Equivalents and Net AssetsTREPS 02-Jun-2025 DEPO 1011.38474749347.4777
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-14.2625 -59.4790
Total -2.8778 -12.0013
Treasury Bills91 Days Treasury Bill 17-Jul-20251.19035000004.9641
Treasury Bills91 Days Treasury Bill 21-Aug-20251.18415000004.9379
Treasury Bills91 Days Treasury Bill 28-Aug-20250.70973000002.9596
Total 3.0841 12.8616
Derivatives-FuturesLupin Limited 26/06/20256.187913132525.8054
Derivatives-FuturesDr. Reddy's Laboratories Limited 26/06/20254.439214812518.5127
Derivatives-FuturesSun Pharmaceutical Industries Limited 26/06/20252.94577280012.2843
Derivatives-FuturesAurobindo Pharma Limited 26/06/20252.59009350010.8011
Total 16.1628 67.4035
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.